Majority Of Americans Say Political Violence Now A 'Major Problem,' Worried Democracy Is At Riskhttps://t.co/2brJJFd5ww https://t.co/ZcSIDwgK1d ...

Octogenarian Ugandan leader Museveni’s bid to extend his near four-decade rule underscores an anti-democratic trend in Africa https://t.co/fG3Jdj4aOM ...

Everyone's looking to NYC for Democratic strategy lessons. But the real test is in a majority-Latino district in Arizona where a different primary will end in two weeks, writes @Erika_D_Smith (via @opinion) https://t.co/5dx5oGDxrO ...

There is a conceivable future in which Myanmar’s jailed leader eventually emerges from detention as a figurehead for a new, democratic government. For now, all the evidence points to a different outcome https://t.co/VUpdfLdcxCPhoto: Getty Images https://t.co/xt8pQo2WCz ...

It takes weeks of haggling by ministers and their diplomatic underlings to craft the European Union’s “conclusions”. Autocrats from China, Russia, Turkey and beyond are too often able to run rings around them https://t.co/iefPRkyuxQ ...

If this insane spending bill passes, the America Party will be formed the next day.Our country needs an alternative to the Democrat-Republican uniparty so that the people actually have a VOICE. ...

Core Insights - Crinetics Pharmaceuticals is set to present long-term efficacy and safety data for its investigational drug PALSONIFY (paltusotine) in acromegaly, demonstrating both biochemical and symptom control with a well-tolerated safety profile [1][2] - The company will also showcase Phase 2 trial results for atumelnant in congenital adrenal hyperplasia (CAH) and data from early-stage development programs in Graves' hyperthyroidism and orbitopathy at the Endocrine Society's Annual Meeting, ENDO 2025 [1][3] PALSONIFY Presentations - Four abstracts will report results from the PALSONIFY development program, including an oral presentation on long-term efficacy, safety, and symptom control in acromegaly patients switching from injectable somatostatin receptor ligands to once-daily oral PALSONIFY [2][4] - Three poster presentations will cover symptom stability in acromegaly, patient-reported outcomes from PATHFNDR-1 and PATHFNDR-2, and open-label extension data from PATHFNDR-2 [2] Atumelnant Presentations - Three abstracts will focus on atumelnant, including an oral presentation of Phase 2 trial results in CAH, highlighting reductions in adrenal volume and significant decreases in potent 11-oxygenated androgens [3][7] Early-Stage Pipeline - Crinetics will present new data from its early-stage pipeline, including findings related to CRN12755 for Graves' hyperthyroidism and orbitopathy [4][8] Company Overview - Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel therapeutics for endocrine diseases and related tumors, with PALSONIFY and atumelnant as its lead candidates [11]

The thing about the MAGA movement is they're the worst winners in human history. I mean, you're you're you're you're like a world-class athlete. Have you ever seen anyone win and act like such a jerk as the MAGA people? I mean, I've seen it, but they're not my friends, right? They're not my people. [Music] This is perhaps the episode of the best people that I dreamed about that I thought would never come to be. Um, you two have an outsized role in my life. From untamed to the role of a stepparent with the u ...

Little known New York State Assemblyman Zoran Mam Donnie took the internet by storm this week. Shocked the world, beating out Andrew Cuomo for the Democratic nomination. Here's the poly market chart.Just crazy. One month ago, Cuomo was at 93%. Zoron had a 6% chance.My lord, what a flip. A couple of things happened that led to this. Obviously, a bunch of viral moments.He's a great speaker. Reminds me of Vake in in that regard. Really good.uh you know in debates and and speaking publicly started rising in the ...

Former Obama White House chief of staff and longtime Democratic strategist Bill Daly calling out his own party for its current direction. In a Wall Street Journal op-ed criticizing a New York mayoral candidate, Zoran Mandani Daly writes the following. He says, quote, "Democrats rightly deplore the Republican party for capitulating to Donald Trump and an agenda that threatens democracy and decency, but we'd better pause and note how our own party is creeping dangerously close to an agenda that's equally outl ...